Vertex Pharmaceuticals target price raised to $563 from $500 by Stifel
VRTX•Stifel raised its target price for Vertex Pharmaceuticals to $563 from $500.
Related News
Rexford Industrial Realty target price raised to $42 from $39
REXR•
Cipher Digital target price cut to $19 from $30 by Rosenblatt Securities
CIFR•
Scholar Rock to participate in UBS, Jefferies investor conferences
SRRK•
BMO partners with Redion to expand travel insurance offering
BMO•
Apple Inc.: Monness Crespi Hardt raises target price to $360 from $355
AAPL•